Percutaneous Mitral Valve Repair versus Optimal Medical Therapy in Patients with Functional Mitral Regurgitation: A Systematic Review and Meta-Analysis
Table 1
Baseline characteristics of included patients.
Author (year)
Average Age
Average MR Grade
Male Sex %
Previous Afib %
NYHA III-IV (%)
Average LVEF %
Overall (Treatment/Control)
Overall (Treatment/Control)
Overall (Treatment/Control)
Overall (Treatment/Control)
Overall (Treatment/Control)
Velazquez, 2015
73.7 (73.7)
3-4+
57.1 (59.8/54.4)
33 (33/33)
33.21 (34/32)
Asgar, 2016
71.8 (75/68)
3-4+
75.37 (74/77)
39 (35/43)
74.5 (73/76)
36 (37/35)
Armeni, 2016
71 (71/71)
73.39 (73/74)
49.48 (53/40.7)
87.87 (88.5/86.4)
36.11 (36.8/34.5)
Giannini, 2016
75.5 (75/76)
3-4+
66.5 (70/63)
61.55 (64.9/58.2)
79 (78.2/79.8)
41.75 (41.5/42)
Geis, 2017
62.01 (68.2/54.3)
41.57 (74.4/0.65)
58.82 (61.6/52.8)
54.65 (54.4/55.2)
Obadia, 2018
70.35 (70.1/70.6)
3-4+
74.65 (78.9/70.4)
51.29 (55.6/43)
56.8 (86.3/61.9)
36.07 (37.22/33.85)
Kortlandt, 2018
74.02 (73.96/74.15)
3-4+
54.93 (56.5/51.9)
46.3 (65.0/23)
25.45 (25/26)
Stone, 2018
72.26 (71.7/72.8)
3-4+
64.01 (66.6/61.5)
55.22 (57.3/53.2)
60.86 (57/64.6)
31.3 (31.3/31/3)
MR: mitral regurgitation; Afib: atrial fibrillation; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction.
